Solventum Corporation
Solventum Corporation
Your view on SOLV
Overview
What the company does, where it operates, and who runs it.
About Solventum Corporation
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Bryan C. Hanson
- Headquarters
- US
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Bryan C. Hanson
- Headquarters
- US
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.
The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents.
The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms.
The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Solventum Corporation from FRC's valuation model, read against the market price. SOLV last traded at $88.65, 99.8× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Solventum Corporation. Starting points for Solventum Corporation: P/E 99.8, EPS $0.91, beta 0.75 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Solventum Corporation. Solventum Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Solventum Corporation. Trailing twelve-month EPS for Solventum Corporation stands at $0.91. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$85.60
average of 10 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy7
- Hold1
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $1.77 | $1.77 | $7.25 | $7.60 |
| Low estimate | $1.55 | $1.51 | $7.14 | $7.30 |
| High estimate | $1.90 | $1.90 | $7.51 | $7.83 |
| No. of analysts | 8 | 6 | 9 | 10 |
| Year-ago EPS | $1.57 | $1.48 | $8.88 | — |
| Growth | +12.9% | +19.3% | -18.4% | — |
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $2.09B | $2.08B | $8.25B | $8.57B |
| Low estimate | $2.06B | $2.05B | $8.20B | $8.49B |
| High estimate | $2.10B | $2.10B | $8.39B | $8.72B |
| No. of analysts | 8 | 5 | 11 | 11 |
| Year-ago revenue | $2.00B | $2.01B | $8.32B | — |
| Growth | +4.4% | +3.8% | -0.9% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Solventum Corporation. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- BAXBaxter International Inc.Medical - Instruments & Supplies$13.2B
- BDXBecton, Dickinson and CompanyMedical - Instruments & Supplies$59.0B
- CNVVFConvaTec Group PlcMedical - Instruments & Supplies$7.1B
- COOThe Cooper Companies, Inc.Medical - Instruments & Supplies$11.8B
- HSICHenry Schein, Inc.Medical - Distribution$9.4B
- ICUIICU Medical, Inc.Medical - Instruments & Supplies$4.5B
- MMSIMerit Medical Systems, Inc.Medical - Instruments & Supplies$5.2B
- NVSTEnvista Holdings CorpMedical - Instruments & Supplies$3.9B
More Medical - Instruments & Supplies companies
- WSTWest Pharmaceutical Services, Inc.NYSE$29.1B
- XRAYDENTSPLY SIRONA Inc.NASDAQ$1.8B
- YBGJYubo International Biotech LimitedOTC$1M
- ZJYLJin Medical International Ltd.NASDAQ$28M
- SHWGYShandong Weigao Group Medical Polymer Company LimitedOTC$3.0B
- SMTISanara MedTech Inc.NASDAQ$301M
- SOAGYSartorius AGOTC$82.3B
- SRTOYSartorius Stedim Biotech S.A.OTC$209.8B
- SSSGYSartorius AGOTC$15.8B
- STAASTAAR Surgical CompanyNASDAQ$1.3B
- STSSSharps Technology, Inc.NASDAQ$54M
- STVNStevanato Group S.p.A.NYSE$4.2B
ETFs holding Solventum Corporation
% of the fund
- VOOVanguard S&P 500 ETF$1.0T in assets0.02%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.02%
- VBVanguard Small-Cap ETF$76.9B in assets0.15%
- RSPInvesco S&P 500 Equal Weight ETF$101.8B in assets0.19%
- CSDInvesco S&P Spin-Off ETF$214M in assets4.60%
- FXHFirst Trust Health Care AlphaDEX Fund$1.2B in assets2.25%
- DUSADavis Select U.S. Equity ETF$1.3B in assets2.17%
- DWLDDavis Select Worldwide ETF$584M in assets1.98%
Largest holders first, then the funds most concentrated in SOLV.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Solventum Corporation, and how their positions are changing. At a $15.07B market value, institutional positions materially move Solventum Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Solventum Corporation executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Solventum Corporation. Solventum Corporation is a $15.07B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Solventum Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Solventum Corporation. Coverage tracks Solventum Corporation within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Solventum Corporation.